However, the mutation that has been described in more than 90% of LPL cases has also been demonstrated less frequently in chronic lymphocytic leukemia/small lymphocytic lymphoma, follicular lymphoma, mantle cell lymphoma, and particularly in MZL [18]. This evidence concerns the gene LPL and marginal zone lymphoma.